N-acetylcysteine (NAC) shows promise as a safe, fertility-sparing, non-hormonal treatment for endometriosis.

Disclaimer: This paper is for informational and educational purposes only, based on research available as of early 2026. It does not provide medical advice or endorse the use of unapproved compounds. This information is for informational purposes only and does not replace professional medical advice. Always consult a licensed healthcare provider for concerns about your health.

N-acetylcysteine (NAC) shows promise as a safe, fertility-sparing, non-hormonal treatment for endometriosis. Research indicates it significantly reduces pelvic pain, shrinks endometrioma cysts, and lowers inflammatory markers, making it a valuable therapeutic option for symptom management and reproductive planning.

Abstract

Endometriosis is an estrogen-dependent, chronic inflammatory condition heavily associated with pelvic pain and infertility. Current first-line medical therapies (such as hormonal contraceptives) are highly effective at managing symptoms but prevent pregnancy and can cause notable adverse effects. N-acetylcysteine (NAC) has emerged as a compelling, safe, and inexpensive non-hormonal alternative. This paper explores the mechanisms of action, clinical efficacy, and future therapeutic potential of NAC in women with endometriosis.

Introduction

The pathogenesis of endometriosis is deeply intertwined with oxidative stress, chronic inflammation, and cellular proliferation. Retrograde menstruation exposes the peritoneal cavity to excess reactive oxygen species (ROS) and free iron, which perpetuate local inflammation and promote the growth of ectopic endometrial tissues. NAC acts as a direct precursor to glutathione—the body's most abundant intracellular antioxidant. By mitigating oxidative stress, downregulating inflammatory pathways, and inhibiting cell proliferation, NAC addresses the root biochemical drivers of endometriosis.

Mechanisms of Action

NAC exerts several key biochemical and molecular effects on endometriotic cells:

• Antioxidant & Glutathione Synthesis: NAC restores the body's antioxidant capacity, scavenging free radicals and neutralizing inflammatory cascades.

• Anti-Proliferative & Pro-Apoptotic Effects: Studies show that NAC shifts endometriotic cells from a state of rapid proliferation to apoptosis (programmed cell death) and cell differentiation. It inhibits the tyrosine-kinase c-Src, suppressing the migratory and adhesive capabilities of endometriotic tissue.

• Downregulation of Inflammatory Markers: NAC limits the expression of pro-inflammatory cytokines and enzymes such as TNF-\(\alpha \), IL-6, IL-8, and COX-2. Lowering COX-2, for instance, reduces the localized production of prostaglandins, which are a major trigger for endometriosis-related pain.

  
  

Clinical Efficacy

Recent clinical trials and observational studies highlight significant benefits for women undergoing NAC treatment:

• Pain Reduction: Oral supplementation with NAC (typically at doses between 600mg to 1200mg per day is associated with a dramatic decrease in endometriosis-associated pain, including dysmenorrhea, dyspareunia, and chronic pelvic pain. This reduction in pain typically leads to a decreased reliance on NSAIDs and other analgesics.

• Cyst Size Reduction: Unlike some conservative treatments that only halt the growth of lesions, NAC has been shown in ultrasound-confirmed studies to actively reduce the mean diameter and volume of ovarian endometriomas over 3- to 6-month treatment periods.

• Biomarker Improvement: Treatment with NAC reliably decreases serum CA125 levels, a well-known clinical marker for inflammation and endometriosis severity.

• Fertility Outcomes: Because NAC is non-hormonal, it provides an option for patients actively trying to conceive. Clinical data shows higher rates of unassisted pregnancy in women with a history of infertility who undergo NAC therapy.

  
  

Safety and Tolerability

A major advantage of NAC supplementation is its virtual absence of side effects. Traditional hormonal therapies for endometriosis—such as progestins or GnRH agonists—can cause weight gain, mood disturbances, and bone mineral density loss. Conversely, NAC is generally well-tolerated, making it suitable for long-term use, especially for women who cannot tolerate or who refuse hormonal therapy.

Limitations and Future Research

While initial pilot studies and clinical cohorts are overwhelmingly positive, the scientific community notes a need for larger-scale, multi-center randomized controlled trials (RCTs). Furthermore, researchers are evaluating combination therapies; for example, supplementing NAC alongside alpha-lipoic acid and bromelain has shown synergistic effects in addressing chronic pelvic inflammation. 

Conclusion

N-acetylcysteine (NAC) represents a promising, multi-faceted, and safe approach to managing endometriosis. By reducing oxidative stress, shrinking endometriomas, alleviating chronic pain, and preserving fertility, NAC offers a vital therapeutic alternative for women seeking non-hormonal solutions

References

1. Efficacy of N-Acetylcysteine on Endometriosis-Related Pain, Size Reduction of Ovarian Endometriomas, and Fertility Outcomes https://pmc.ncbi.nlm.nih.gov/articles/PMC10048621/

2. A Promise in the Treatment of Endometriosis: An Observational Cohort Study on Ovarian Endometrioma Reduction by N-Acetylcysteine https://pmc.ncbi.nlm.nih.gov/articles/PMC3662115/

3. Dietary supplements for treatment of endometriosis: A review https://pmc.ncbi.nlm.nih.gov/articles/PMC8972862/

4. Administration of N-acetylcysteine influence the expression of apoptotic genes in the granulosa cells of infertile women diagnosed with endometriosis https://pmc.ncbi.nlm.nih.gov/articles/PMC12957339/

5. N-acetylcysteine stimulates organelle malfunction in endometriotic cells via IFN-gamma signaling https://www.nature.com/articles/s41598-025-00195-z

6. Oxidative Imbalance in Endometriosis-Related Infertility—The Therapeutic Role of Antioxidants https://pmc.ncbi.nlm.nih.gov/articles/PMC11204103/

7. The Combination of N-Acetyl Cysteine, Alpha-Lipoic Acid, and Bromelain Shows High Anti-Inflammatory Properties in Novel In Vivo and In Vitro Models of Endometriosis https://pmc.ncbi.nlm.nih.gov/articles/PMC4415658/

8. N-Acetylcysteine (NAC) and Endometriosis https://internationalendo.com/nac-for-endometriosis/

9. Effectiveness of an antioxidant preparation with N-acetyl cysteine, alpha lipoic acid and bromelain in the treatment of endometriosis-associated pelvic pain: LEAP study https://www.sciencedirect.com/science/article/abs/pii/S0301211518303300

10. Endometriosis Treatment: Role of Natural Polyphenols as Anti-Inflammatory Agents https://pmc.ncbi.nlm.nih.gov/articles/PMC10343861/

11. Nonsteroidal anti‐inflammatory drugs for pain in women with endometriosis https://pmc.ncbi.nlm.nih.gov/articles/PMC6464974/

12. Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts: a patient preference study https://www.sciencedirect.com/science/article/abs/pii/S0301211513006180

13. Managing Endometriosis Through Diet and Nutrition: The Power of Turmeric and N-Acetylcysteine https://mjwcooper.com.au/managing-endometriosis-through-diet-and-nutrition-the-power-of-turmeric-and-n-acetylcysteine/